Presentations

Documents

Order by : Name | Date | Hits | [ Descendent ]

Why Should We Care About NAFLD? Why Should We Care About NAFLD?

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 1667

Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

NASH Therapeutics: Targets Under Evaluation in Early Phase Trials NASH Therapeutics: Targets Under Evaluation in Early Phase Trials

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 1668

Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

Heterogeneity of NAFLD in humans Heterogeneity of NAFLD in humans

hot!
Date added: 02/16/2018
Date modified: 02/16/2018
Filesize: 256 Bytes
Downloads: 1689

Invited oral presentation given by UHEL at the Symposium on NAFLD during The Endocrine Society Annual Meeting (ENDO 2017), Orlando, USA, 1st April 2017

Non-alcoholic fatty liver diseases Non-alcoholic fatty liver diseases

hot!
Date added: 05/22/2016
Date modified: 05/22/2016
Filesize: 4.68 MB
Downloads: 1693

Presentation given by CNR at Foresight Workshop: "Theranostics for P4 Medicine", Florence, Italy, 21st - 23rd March 2016

Serum markers of fibrosis in NASH Serum markers of fibrosis in NASH

hot!
Date added: 03/10/2018
Date modified: 03/10/2018
Filesize: 256 Bytes
Downloads: 1702

Oral presentation given by UMC & NB at the EASL International Liver Congress (ILC), Amsterdam, Netherlands, 19th - 23rd April 2017

Natural history and genetic modifiers of NAFLD Natural history and genetic modifiers of NAFLD

hot!
Date added: 02/16/2018
Date modified: 02/16/2018
Filesize: 256 Bytes
Downloads: 1719

Oral presentation given by UNEW at the EASL International Liver Congress (ILC), Amsterdam, Netherlands, 19th - 23rd April 2017

Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin... Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin...

hot!
Date added: 03/13/2018
Date modified: 03/13/2018
Filesize: 256 Bytes
Downloads: 1728

"Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin Resistance and Liver Histology in Patients with NASH"

Oral presentation given by CNR at the 5th EASD-NAFLD Study Group meeting, Gothenburg, Sweden, 8th - 9th May 2017

European NAFLD Consortia: EPoS, LITMUS & The European NAFLD Registry European NAFLD Consortia: EPoS, LITMUS & The European NAFLD Registry

hot!
Date added: 08/10/2019
Date modified: 08/10/2019
Filesize: 256 Bytes
Downloads: 1729

Presentation given by UNEW at the EASL International Liver Congress, Vienna, Austria, 10th - 14th April 2019

The European NAFLD registry The European NAFLD registry

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 1736

Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

Novel Serum Biomarkers of Fibrogenesis Novel Serum Biomarkers of Fibrogenesis

hot!
Date added: 11/25/2017
Date modified: 11/25/2017
Filesize: 256 Bytes
Downloads: 1746

Oral presentation given by UMC at the Nash-Tag conference, Park City, Utah, USA, 5th - 7th January 2017